44687-25MG Display Image

5-Bromo-4-chloro-3-indolyl beta-D-ribofuranoside, >=98.0% (HPLC)

Code: 44687-25MG D2-231

Application

Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria

Legal Information

Supplied by Glycos...


read more

Your Price
£87.10 25MG
£104.52 inc. VAT

Application

Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria

Legal Information

Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

assay≥98.0% (HPLC)
formpowder
InChI keyRYLVNYDICPAOQR-HUXSOILUSA-N
InChI1S/C13H13BrClNO5/c14-5-1-2-6-9(10(5)15)7(3-16-6)20-13-12(19)11(18)8(4-17)21-13/h1-3,8,11-13,16-19H,4H2/t8-,11-,12-,13-/m1/s1
optical activity[α]/D -102.0±3.0°, c = 1 in methanol
Quality Level100
SMILES stringOC[C@H]1O[C@@H](Oc2c[nH]c3ccc(Br)c(Cl)c23)[C@H](O)[C@@H]1O
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
44687-100MG
Unit:100MG
List Price: £267.00
Source:List Price
ADD
Cas Number518033-33-5
This product has met the following criteria: